Italian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
diabetes mellitus type 2/fatica
Il collegamento viene salvato negli appunti
8 risultati
Use of compounds that are able to increase the serum IGF-1 level for the preparation of a therapeutical composition for treatment of various disease states associated with a reduced IGF-1 serum level in humans and animals
Solo gli utenti registrati possono tradurre articoli
Entra registrati
The present invention relates to the use of one or more compounds that are capable of increasing the serum level of insulin-like growth factor 1 (IGF-1) for the preparation of a therapeutical composition, in particular in the form of a food supplement, for the treatment of subjects suffering from
Use of compounds that are able to increase the serum IGF-1 level for the preparation of a therapeutical composition for treatment of various disease states associated with a reduced IGF-1 serum level in humans and animals
Solo gli utenti registrati possono tradurre articoli
Entra registrati
TECHNICAL FIELD
The present application relates to the use of one or more compounds that are capable of increasing the serum level of insulin-like growth factor 1 (IGF-1) for the preparation of a therapeutical composition, in particular, in the form of a food supplement, for the treatment of
Treatment and prevention of Th1 and `autoimmune` diseases effected with antibiotics and/or angiotensin inhibition
Solo gli utenti registrati possono tradurre articoli
Entra registrati
BACKGROUND OF INVENTION
It is currently believed that the diseases known as "autoimmune" diseases are caused by the body's immune system attacking the body itself. But I have discovered that these so-called "autoimmune" diseases are actually caused by stealthy intra-cellular bacteria. I have
Probiotic Bifidobacterium adolescentis strains
Solo gli utenti registrati possono tradurre articoli
Entra registrati
FIELD OF THE INVENTION
The present invention relates to novel isolated strains of Bifidobacterium adolescentis which are capable of i) increasing the trans-epithelial electrical resistance (TER) of a Caco-2 cell monolayer after 10 h treatment to more than 120% of TER at treatment start, ii) inducing
Bioactive alkaloid compositions and their medical uses
Solo gli utenti registrati possono tradurre articoli
Entra registrati
CROSS-REFERENCE TO RELATED APPLICATIONS
This application claims the benefit under 35 U.S.C. .sctn.119(a) of Danish Application No. PA 2013 00427, filed Jul. 14, 2013, entitled Novel Bioactive Alkaloids and Alkaloid Fractions Derivable From Ribes Species, the disclosure of which is incorporated by
Fluorinated cyclic amides as dipeptidyl peptidase IV inhibitors
Solo gli utenti registrati possono tradurre articoli
Entra registrati
FIELD OF THE INVENTION
The present invention relates to new therapeutically active and selective inhibitors of the enzyme dipeptidyl peptidase-IV (hereinafter "DPP-IV"), pharmaceutical compositions comprising the compounds and the use of such compounds for treating diseases that are associated with
Moringa extract
Solo gli utenti registrati possono tradurre articoli
Entra registrati
TECHNICAL FIELD
The present invention relates to a moringa extract, a PPAR activator containing a moringa extract, a composition containing a moringa extract, a method for producing them, and foodstuff containing them.
BACKGROUND ART
A plant belonging to the genus Moringa (also simply referred to
Synergistic anti-diabetic compositions
Solo gli utenti registrati possono tradurre articoli
Entra registrati
TECHNICAL FIELD
The present invention is concerned with improved synergistic compositions effective in the treatment of diabetes and/or hyperglycemia. In particular, the present invention is concerned with synergistic compositions comprising inulin preparations with defined degree of polymerisation
Il database di erbe medicinali più completo supportato dalla scienza
- Funziona in 55 lingue
- Cure a base di erbe sostenute dalla scienza
- Riconoscimento delle erbe per immagine
- Mappa GPS interattiva - tagga le erbe sul luogo (disponibile a breve)
- Leggi le pubblicazioni scientifiche relative alla tua ricerca
- Cerca le erbe medicinali in base ai loro effetti
- Organizza i tuoi interessi e tieniti aggiornato sulle notizie di ricerca, sperimentazioni cliniche e brevetti
Digita un sintomo o una malattia e leggi le erbe che potrebbero aiutare, digita un'erba e osserva le malattie ei sintomi contro cui è usata.
* Tutte le informazioni si basano su ricerche scientifiche pubblicate
